Tevogen Bio Holdings Inc. (NASDAQ:TVGN) does about 14.23M shares in volume on a normal day but saw 11236078 shares change hands in the recent trading day. The company now has a market cap of 467.58M USD. Its current market price is $2.74, marking a decrease of -10.16% compared to the previous close of $3.05. The 52 week high reached by this stock is $21.09 whilst the lowest price level in 52 weeks is $0.26.
Tevogen Bio Holdings Inc. (TVGN) has a 20-day trading average at $1.18 and the current price is -87.01% off the 52-week high compared with 971.99% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.76 and its 200-day simple moving average is $2.56. If we look at the stock’s price movements over the week, volatility stands at 32.82%, which increases to 33.01% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 75.72 to suggest the stock is overbought.
The consensus objective for the share price is $4.20, suggesting that the stock has a potential upside of 34.76% over the period.
The current price level is 131.92%, 260.12%, and 7.13% away from its SMA20, SMA50, and SMA200 respectively, with the TVGN price moving below the 50-day SMA on current market day. Tevogen Bio Holdings Inc. (TVGN) stock is up 52.22% over the week and 588.44% over the past month. Its price is -75.38% year-to-date and -74.63% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 34.76 percent from here.
Outstanding shares total 170.65M with insiders holding 93.39% of the shares and institutional holders owning 3.85% of the company’s common stock. The company has a return on equity of 268.90%. The beta has a value of 0.22.
